April 24, 2019
Scientists Solve 3D Structure of Melatonin Receptors, Path to Better Medications in Sight
Bryan L. Roth, MD, PhD, and colleagues analyzed two melatonin receptors bound to compounds to show their precise differences and open the door to more targeted treatments for sleep disorders, diabetes, cancers, and other conditions. The research was published in Nature.